Tag: Featured

Stories featured at the top of tobaccoreporter.com

  • FDA Orders Spectrum Research Cigarettes

    FDA Orders Spectrum Research Cigarettes

    Photo: Simone van den Berg | Dreamstime

    The U.S. Food and Drug Administration (FDA) in coordination with the National Institute on Drug Abuse and other organizations, has ordered 3.6 million Spectrum-brand variable nicotine research cigarettes from 22nd Century Group.

    The research cigarettes will be used for independent, scientific studies to validate the public health benefits identified by the FDA and others of implementing a national standard requiring all cigarettes to contain minimally or non-addictive levels of nicotine.

    “We are proud to partner with public health researchers and look forward to the next step in the FDA’s plan to reduce the nicotine content of all cigarettes sold in the U.S. to minimally or non-addictive levels,” said James A. Mish, chief executive officer of 22nd Century Group, in a statement.

    “22nd Century remains the leader in reduced nicotine content tobacco products. We believe when the FDA mandate ultimately goes into effect, we will be well-positioned to capitalize on this tremendous opportunity, and we are committed to licensing our technology to make it possible for every cigarette manufacturer in the U.S. to comply with the standard.”

    According to 22nd Century Group, the selection of Spectrum cigarettes is not connected to 22nd Century’s modified risk tobacco application for the company’s reduced nicotine content VLN cigarettes, which feature 95 percent les nicotine than conventional brands.

    22nd Century believes that authorization of the company’s MRTP application is imminent, and it plans to launch VLN cigarettes within 90 days of authorization.

  • Tobacco Firms Lauded for Sustainability

    Tobacco Firms Lauded for Sustainability

    Photo: Gerd Altmann from Pixabay

    CDP, a global environmental nonprofit, has recognized Japan Tobacco and Imperial Brands for their leadership in corporate sustainability.

    JT achieved a place on CDP’s prestigious A List for tackling climate change as well as acting to protect water security for the second consecutive year. In addition, in December 2020, the company endorsed the recommendations of the Task Force on Climate-related Financial Disclosures.

    “We are delighted to be included in the CDP’s Climate A List and Water A List for the second consecutive year. This clearly reflects our continued efforts to reduce our environmental footprint and our transparency in disclosing information,” said Kazuhito Yamashita, member of the board and senior vice president, chief sustainability officer, compliance and general affairs in a press note.

    Imperial Brands too secured a place on CDP’s prestigious “A List” for tackling climate change for the second successive year.

    The business has been recognized for its actions to cut emissions, mitigate climate risks and transition to a lower-carbon economy, based on the data reported through CDP’s 2020 climate change questionnaire.

    Stefan Bomhard

    “To retain our A rating is a tremendous achievement that highlights our commitment to reducing our carbon footprint,” said Imperial Brands Chief Executive Stefan Bomhard in a statement. “The data we provided for review by CDP was extensive and I’d like to thank everyone who was involved in pulling together such an impressive submission.”

    CDP’s annual environmental disclosure and scoring process is widely acknowledged as the gold standard of corporate environmental transparency. Japan Tobacco and Imperial Brands are among a small number of A List companies out of more than 5,800 that were scored.

    A detailed and independent methodology is used by CDP to assess companies based on the comprehensiveness of disclosure, awareness and management of environmental risks and demonstration of best practices associated with environmental leadership, such as setting ambitious and meaningful targets.

    “We extend our congratulations to all the companies on this year’s A List,” said Paul Simpson, CEO of CDP. “Taking the lead on environmental transparency and action is one of the most important steps businesses can make, and is even more impressive in this challenging year marked by Covid-19.”

  • FDA Authorizes IQOS Holder and Charger

    FDA Authorizes IQOS Holder and Charger

    The U.S. Food and Drug Administration (FDA) has issued a marketing order to Philip Morris Products authorizing the sale of the IQOS 3 system holder and charger, the agency announced on Twitter.

    The newly authorized version has minor design differences from the previous version authorized in April, including how the holder inserts into the charger, changes to the charging connectors and LED indicator lights, a new touch feedback feature, and an option to reduce the perceived heat from the tobacco aerosol inhaled by users.

    Data on product use suggest no differences among user populations from the previous version, including no new concerns regarding product initiation or use among youth and young adults.

    “The issuance of this marketing granted order confirms that you have met the requirements of section 910(c) of the FD&C Act and authorizes marketing of your new tobacco product,” the FDA wrote in a letter to Philip Morris Products.

    “Under the provisions of section 910, you may introduce or deliver for introduction into interstate commerce the tobacco product, in accordance with the marketing order requirements outlined in this order, including all appendices.”

    The agency stressed that the marketing order does not mean any version of the IQOS system holder and charger can be marketed as “safe” or “FDA approved.”

    “There are no safe tobacco products,” the FDA wrote.

    The previous version of the IQOS system holder and charger was initially allowed for sale in the U.S. following the FDA’s issuance of a marketing order in April 2019. The company later submitted another premarket tobacco application requesting to market an updated version of the device holder and charger.

    On July 7, 2020 the FDA authorized the marketing of the IQOS 2.4 tobacco heating system as a modified risk tobacco product with a reduced exposure claim. IQOS 2.4 is the first next-generation inhalable tobacco product to be authorized as a modified risk tobacco product.

    “Altria’s 10-year vision is to responsibly lead the transition of adult smokers to a non-combustible future. IQOS is a key part of that future and we’re excited to build on our first-mover advantage with the enhanced IQOS 3 device which has performed successfully in international markets,” said Jon Moore, president and chief executive officer of PM USA, which has an exclusive agreement to commercialize the IQOS system in the U.S., in a statement.

    IQOS is currently available in the Atlanta, Georgia, Richmond, Virginia and Charlotte, North Carolina markets.

  • Biden Nominates Becerra for HHS

    Biden Nominates Becerra for HHS

    Xavier Becerra (Photo: State of California Department of Justice)

    U.S. President-elect Joseph R. Biden Jr. has selected Xavier Becerra, the Democratic attorney general of California, as his nominee for secretary of health and human services, reports The New York Times.

    As attorney general in California, Becerra has been at the forefront of legal efforts on health care, leading 20 states and the District of Columbia in a campaign to protect the Affordable Care Act from being dismantled by his Republican counterparts. He has also been vocal in the Democratic Party about fighting for women’s health.

    In a tweet, Derek Yach, president of the Foundation for a Smoke-Free World, described the choice as a “serious missed opportunity.”

    “At a time of public health crisis deep expertise in public health, medicine and science should matter,” Yacht wrote. “Sadly, this is not apparent in the pick of the lead cabinet health voice.”

    The Food and Drug Administration (FDA), which regulates the tobacco industry in the United States, is a federal agency of the Department of Health and Human Services. It is currently led by Alex Azar.

    Earlier, Biden named former FDA Commissioner David Kessler to his Covid-19 advisory board. A pediatrician, lawyer and author, Kessler led the FDA from 1990 to 1997. During his tenure, he tried but failed to bring cigarettes under the agency’s jurisdiction. The industry, which opposed regulation at the time, successfully challenged the FDA in court (FDA v. Brown & Williamson Tobacco Corp.). The Supreme Court ultimately ruled that the FDA did not have the power to enact and enforce the regulations in question.

    Kessler’s wish to see tobacco regulated by the FDA was eventually granted by Congress in June 2009 through the passage of the Family Smoking Prevention and Tobacco Control Act.

    Our contributor Patricia Kovacevic discusses the potential impact on tobacco and nicotine of the new administration in this month’s issue of Tobacco Reporter.

  • Darrell Thomas Joins BAT Board

    Darrell Thomas Joins BAT Board

    Darrell Thomas (Photo: BAT)

    Darrell Thomas will join the board of British American Tobacco (BAT) as an independent nonexecutive director and member of the Audit and Nominations Committees, effective Dec. 7, 2020, the company announced in a statement.

    Thomas brings financial, regulatory and U.S. experience to the BAT board gained during his extensive career. Thomas is currently vice president and treasurer for Harley-Davidson., having previously held several senior finance positions including interim chief financial officer for Harley-Davidson., vice president and chief financial officer for Harley-Davidson Financial Services., and vice president and assistant treasurer for PepsiCo.

    Prior to joining PepsiCo, Thomas had a 19-year career in banking with Commerzbank Securities, Swiss Re New Markets, ABN Amro Bank and Citicorp/Citibank where he held various capital markets and corporate finance roles.

     

  • Leadership Change at BAT Kenya

    Leadership Change at BAT Kenya

    Photo: Bokgallery | Dreamstime

    Beverley Spencer-Obatoyinbo will resign as managing director of British American Tobacco Kenya effective Dec. 31, following the end of her assignment.

    “The board would like to thank Beverly for her significant contribution to BAT Kenya,” the company said in a statement. “Over the past four years, Spencer-Obatoyinbo has transformed the business from a portfolio, value and people perspective. She leaves a legacy of energizing and inclusive leadership and has collaborated extensively with external stakeholders, putting BAT Kenya on the manufacturing and top employer map.”

    Spencer-Obatoyinbo will be succeeded by Crispin Achola. Most recently, Achola worked for Kimberly-Clark Corp., where he held the position of general manager, West, East and Central Africa, and managing director Nigeria.

    Achola worked for BAT from 1999 to 2017, during which he held various senior roles within BAT Kenya and the group, including managing director Mozambique, cluster general manager – Mozambique, Zambia, Zimbabwe and Malawi, and managing director Sudan.

     

  • U.S. House Votes to Decriminalize Marijuana

    U.S. House Votes to Decriminalize Marijuana

    Photo: forcal35 from Pixabay

    The U.S. House of Representatives approved a bill decriminalizing marijuana at the federal level on Friday.

    Dubbed the Marijuana Opportunity Reinvestment and Expungement Act, the bill removes cannabis from the list of federally controlled substances and facilitates canceling low-level federal convictions and arrests related to marijuana.

    Among other provisions, the bill calls for an excise tax on cannabis sales and directs the money to be targeted to communities adversely affected by the so-called war on drugs.

    The bill specifically adds incentives for minority-owned businesses to help them enter the cannabis market, which has exploded in recent years given the relaxation in controls in some places within the United States.

    While the legislation is not expected to pass in the Republican-controlled Senate, marijuana has been gaining acceptance in many jurisdictions.

    In a series of ballot initiatives accompanying the recent U.S. presidential election, several states already legalized marijuana. In early December, the United Nations reclassified cannabis as a less dangerous drug.

    Further legalization of marijuana could open new opportunities for tobacco farmers faced with declining demand for their crops.

    In 2018, U.S. Congress legalized hemp with less than 0.3 percent THC, the psychoactive component in cannabis, in all 50 states. Since then, some tobacco farmers have either shifted to growing hemp or added it to their repertoire as an additional income source. Some major tobacco companies have taken stakes in the cannabis industry in recent years. Altria Group, for example, purchased a stake in Cronos Group, a leading global cannabinoid company, headquartered in Toronto, Canada. Pyxus International, the parent company of leaf tobacco merchant Alliance One International, purchased a 40 percent share in Criticality, an integrated industrial hemp company.

    The global industrial hemp market size is expected to reach $15.26 billion by 2027, exhibiting a revenue-based compound annual growth rate (CAGR) of 15.8 percent over the forecast period, according to Grand View Research. Additionally, according to Global Market Insights, the cannabidiol (CBD) market exceeded $2.8 billion in 2019 and is set to grow at around 52.7 percent CAGR between 2020 and 2026, with the global market valuation for CBD crossing $89 billion by 2026.

    The opportunities presented by legal marijuana extend also to suppliers of the tobacco industry. For example. German tobacco machinery maker Hauni recently developed equipment or cannabis processing.

  • ‘Brexit Opportunity for Tobacco Crackdown’

    ‘Brexit Opportunity for Tobacco Crackdown’

    Photo: Gerd Altmann from Pixabay

    Brexit offers the U.K. opportunities to strengthen its tobacco control measures, by creating greater flexibility to respond to industry action and market developments, according to new research from the University of Bath.

    The U.K. is currently bound by EU rules, but will enjoy greater freedom to adopt types of tobacco tax that are more effective at lifting the price of cheap tobacco products, as well as more direct pricing policies such as minimum prices or the imposition of price caps. Higher prices are one of the most effective tobacco control measures.

    Furthermore, with 96 percent of U.K. tobacco products originating from the EU in recent years, a no-deal Brexit is likely to raise cigarette and tobacco prices. HM Treasury has committed to apply new U.K. import tariffs on tobacco from Jan. 1 which, if passed on to consumers, would increase the average price of a typical 20-pack of cigarettes by around £0.30 ($0.40) and a 30-g pouch of roll-your-own tobacco by £1.77.

    “Since higher prices are one of the most effective tobacco control measures, this might be a rare positive from having to trade with the EU on WTO [World Trade Organization] terms,” said Rob Branston of the University’s School of Management, lead author of the study What does Brexit mean for U.K. tobacco control? Brexit offers the chance to improve public health in the U.K., but equally poses a threat to public health if rules are relaxed.”

    The Brexit related flexibility will not extend to Northern Ireland, which will remain part of the EU customs union, following EU rules, and where imports to and from the EU will be tariff-free.

    Northern Ireland will also retain the current photo health warning labels on tobacco packaging, whereas the remainder of the U.K. will switch to using Australian imagery.

    Brexit could also end the import of cheap EU duty-paid tobacco and reduced smuggling due to tougher border checks. The cigarette allowance for travelers from the EU will fall from 800 cigarettes currently, or 1 kg of roll-your-own tobacco, to a duty-free allowance of 200 cigarettes or 250 g of tobacco.

    “Duty-free allowances, tariffs, or regulatory differences will require customs checks at the U.K. border. Such checks might have the benefit of reducing the rate of illicit tobacco in the U.K., boosting revenue to the U.K. government, and the effectiveness of U.K. tobacco tax policy,” Branston said. He estimates higher tariffs would raise in the region of an additional £820 million per year for the government.

    However, the authors assert that the potential benefits of Brexit for U.K. tobacco control will only come to fruition if the government seizes the opportunity by continuing to prioritize policy to address tobacco harms. Allen Gallagher, from the University of Bath’s Tobacco Control Group in the Department for Health, notes that senior members of the current U.K. government have links to neoliberal and free-market “think tanks” like the tobacco-industry funded Institute of Economic Affairs which risks leading the administration to de-prioritize tobacco control.

    “Ultimately, even if good trade agreements are reached, the benefits of Brexit for tobacco regulation will only be realized if there is the political intent to capitalize on the newly gained flexibility,” said Gallagher. “There is a risk that this government’s prioritization of business interests means that the negative health impacts of tobacco will be less of a priority for the government post-Brexit and that tobacco regulation in the U.K. will suffer as a result.” he said.

    With 14.1 percent of the U.K. population smoking as of 2019, tackling tobacco use must remain a public health priority if government aims to make our country ‘smokefree’ in the next decade are to become a reality,” said Co-author Deborah Arnott, chief executive of Action on Smoking on Health.

    “With the Covid-19 pandemic occupying most current health-related attention, it could easily be overlooked that smoking remains the leading cause of preventable death in the U.K., and causes more deaths each and every year than the pandemic has to date.”

     

  • Study: Vapers Quitting Amid Pandemic

    Study: Vapers Quitting Amid Pandemic

    Photo: Sarah J. from Pixabay

    E-cigarette use among U.S. teens and young adults decreased dramatically during the Covid-19 pandemic. Nearly two-thirds of e-cigarette users reporting that they’ve either cut back or quit, according to a new study.

    About 32 percent of e-cigarette users said they quit this year and another 35 percent reported cutting back, according to survey results published Dec. 3 in JAMA Network Open.

    Concerns about lung health were a major factor in their decision, the results indicate. One in four respondents who cut back or quit said they were motivated by concern that vaping could weaken their lungs.

    Research has shown that smokers have a higher risk of severe Covid-19 infection, noted senior researcher Bonnie Halpern-Felsher, a developmental psychologist and professor of pediatrics at Stanford University in California.

    Vapers’ worries were likely also fanned by the 2019 nationwide outbreak of EVALI, which involved thousands of lung injuries related to e-cigarette use, she added.

  • Zimbabwe: Cannabis Could Outstrip Tobacco as Cash Crop

    Zimbabwe: Cannabis Could Outstrip Tobacco as Cash Crop

    Photo: NickyPe from Pixabay

    Zimbabwe’s earnings from cannabis exports could outstrip those of tobacco by almost three times, according to local officials, reports Bloomberg.

    Last year, the southern African nation legalized cultivation of cannabis for medicinal use. Since announcing rules for growing cannabis in September, the government has issued 44 licenses

    Treasury spokesman Clive Mphambela expects sales to reach $1.25 billion in 2021. By comparison, Zimbabwe earned $444 million from the 2020 marketing season that closed in August, according to the Tobacco Industry and Marketing Board.

    John Robertson

    John Robertson, an independent economist based in Harare, said the projections were ambitious. “It’s a massive overestimate and ignores that cannabis is grown in many markets outside of Zimbabwe,” he told Bloomberg.

    “It’s sold in grams, not in kilograms or tons, so there will be disappointment,” Robertson said. “The only enthusiasm will be from producers, but massive supply globally will depress prices.”

    South Africa, Malawi, Zambia and Lesotho have also legalized medicinal cannabis.

    In his budget statement on Nov. 26, Finance Minister Mthuli Ncube said cannabis production for medicinal purposes has “immense potential” to generate export receipts and tax revenues. A so-called cannabis levy will be introduced next year, in line with export values, Ncube said. Taxes of as much as 20 percent will be applied on oils, bulk extracts and dried cannabis flowers.

    Growers, most of whom are locals with international partners, can produce $40 million to $46 million worth of cannabis a month, underpinning Treasury’s “very conservative” estimates, Mphambela said.